Cargando…
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
SIMPLE SUMMARY: Immunotherapy is currently the backbone of new drug treatments for many cancer patients. CXC chemokine ligand 13 (CXCL13) is an important factor involved in recruiting immune cells that express CXC chemokine receptor type 5 (CXCR5) in the tumor microenvironment and serves as a key mo...
Autores principales: | Hsieh, Ching-Hung, Jian, Cheng-Zhe, Lin, Liang-In, Low, Guan-Sian, Ou, Ping-Yun, Hsu, Chiun, Ou, Da-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774093/ https://www.ncbi.nlm.nih.gov/pubmed/35053457 http://dx.doi.org/10.3390/cancers14020294 |
Ejemplares similares
-
Regulative role of the CXCL13-CXCR5 axis in the tumor
microenvironment
por: Tan, Ping, et al.
Publicado: (2018) -
Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
por: Pan, Zijian, et al.
Publicado: (2022) -
CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE
por: Da, Zhanyun, et al.
Publicado: (2016) -
Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases
por: Pan, Zijian, et al.
Publicado: (2022) -
CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer
por: Guo, Jun-Chao, et al.
Publicado: (2016)